United States Depression Drugs Market Report 2017

January 2017 | 122 pages | ID: U85B04CC900EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Depression Drugs

Revenue, means the sales value of Depression Drugs

This report studies sales (consumption) of Depression Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Mylan
• APOTEX
• PRINSTON INC
• TEVA
• ROXANE
• ZYDUS PHARMS
• SUN PHARM
• JUBILANT GENERICS
• GlaxoSmithKline
• Beijing Wansheng
• Huahai
• Jianfeng
• Cadista
• Carbosynth Limited
• LGM Pharma
• Intellipharmaceutics

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• SSRIs
• SNRIs
• TCAs
• Others

Split by applications, this report focuses on sales, market share and growth rate of Depression Drugs in each application, can be divided into

• Clinic
• Hospital

Contents

United States Depression Drugs Market Report 2017

1 DEPRESSION DRUGS OVERVIEW

1.1 Product Overview and Scope of Depression Drugs
1.2 Classification of Depression Drugs
  1.2.1 SSRIs
  1.2.2 SNRIs
  1.2.3 TCAs
  1.2.4 Others
1.3 Application of Depression Drugs
  1.3.1 Clinic
  1.3.2 Hospital
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Depression Drugs (2011-2021)
  1.4.1 United States Depression Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Depression Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES DEPRESSION DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Depression Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Depression Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Depression Drugs Average Price by Manufactures (2015 and 2016)
2.4 Depression Drugs Market Competitive Situation and Trends
  2.4.1 Depression Drugs Market Concentration Rate
  2.4.2 Depression Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DEPRESSION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Depression Drugs Sales and Market Share by States (2011-2016)
3.2 United States Depression Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Depression Drugs Price by States (2011-2016)

4 UNITED STATES DEPRESSION DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Depression Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Depression Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Depression Drugs Price by Type (2011-2016)
4.4 United States Depression Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES DEPRESSION DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Depression Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Depression Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES DEPRESSION DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Depression Drugs Product Type, Application and Specification
    6.1.2.1 SSRIs
    6.1.2.2 SNRIs
  6.1.3 Pfizer Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Mylan
  6.2.2 Depression Drugs Product Type, Application and Specification
    6.2.2.1 SSRIs
    6.2.2.2 SNRIs
  6.2.3 Mylan Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 APOTEX
  6.3.2 Depression Drugs Product Type, Application and Specification
    6.3.2.1 SSRIs
    6.3.2.2 SNRIs
  6.3.3 APOTEX Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 PRINSTON INC
  6.4.2 Depression Drugs Product Type, Application and Specification
    6.4.2.1 SSRIs
    6.4.2.2 SNRIs
  6.4.3 PRINSTON INC Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 TEVA
  6.5.2 Depression Drugs Product Type, Application and Specification
    6.5.2.1 SSRIs
    6.5.2.2 SNRIs
  6.5.3 TEVA Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 ROXANE
  6.6.2 Depression Drugs Product Type, Application and Specification
    6.6.2.1 SSRIs
    6.6.2.2 SNRIs
  6.6.3 ROXANE Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 ZYDUS PHARMS
  6.7.2 Depression Drugs Product Type, Application and Specification
    6.7.2.1 SSRIs
    6.7.2.2 SNRIs
  6.7.3 ZYDUS PHARMS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 SUN PHARM
  6.8.2 Depression Drugs Product Type, Application and Specification
    6.8.2.1 SSRIs
    6.8.2.2 SNRIs
  6.8.3 SUN PHARM Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 JUBILANT GENERICS
  6.9.2 Depression Drugs Product Type, Application and Specification
    6.9.2.1 SSRIs
    6.9.2.2 SNRIs
  6.9.3 JUBILANT GENERICS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
  6.10.2 Depression Drugs Product Type, Application and Specification
    6.10.2.1 SSRIs
    6.10.2.2 SNRIs
  6.10.3 GlaxoSmithKline Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Beijing Wansheng
6.12 Huahai
6.13 Jianfeng
6.14 Cadista
6.15 Carbosynth Limited
6.16 LGM Pharma
6.17 Intellipharmaceutics

7 DEPRESSION DRUGS MANUFACTURING COST ANALYSIS

7.1 Depression Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Depression Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Depression Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Depression Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DEPRESSION DRUGS MARKET FORECAST (2016-2021)

11.1 United States Depression Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Depression Drugs Sales Forecast by Type (2016-2021)
11.3 United States Depression Drugs Sales Forecast by Application (2016-2021)
11.4 Depression Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Depression Drugs
Table Classification of Depression Drugs
Figure United States Sales Market Share of Depression Drugs by Type in 2015
Figure SSRIs Picture
Figure SNRIs Picture
Figure TCAs Picture
Figure Others Picture
Table Application of Depression Drugs
Figure United States Sales Market Share of Depression Drugs by Application in 2015
Figure Clinic Examples
Figure Hospital Examples
Figure United States Depression Drugs Sales and Growth Rate (2011-2021)
Figure United States Depression Drugs Revenue and Growth Rate (2011-2021)
Table United States Depression Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Depression Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Depression Drugs Sales Share by Manufacturers
Figure 2016 Depression Drugs Sales Share by Manufacturers
Table United States Depression Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Depression Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Depression Drugs Revenue Share by Manufacturers
Table 2016 United States Depression Drugs Revenue Share by Manufacturers
Table United States Market Depression Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Depression Drugs Average Price of Key Manufacturers in 2015
Figure Depression Drugs Market Share of Top 3 Manufacturers
Figure Depression Drugs Market Share of Top 5 Manufacturers
Table United States Depression Drugs Sales by States (2011-2016)
Table United States Depression Drugs Sales Share by States (2011-2016)
Figure United States Depression Drugs Sales Market Share by States in 2015
Table United States Depression Drugs Revenue and Market Share by States (2011-2016)
Table United States Depression Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Depression Drugs by States (2011-2016)
Table United States Depression Drugs Price by States (2011-2016)
Table United States Depression Drugs Sales by Type (2011-2016)
Table United States Depression Drugs Sales Share by Type (2011-2016)
Figure United States Depression Drugs Sales Market Share by Type in 2015
Table United States Depression Drugs Revenue and Market Share by Type (2011-2016)
Table United States Depression Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Depression Drugs by Type (2011-2016)
Table United States Depression Drugs Price by Type (2011-2016)
Figure United States Depression Drugs Sales Growth Rate by Type (2011-2016)
Table United States Depression Drugs Sales by Application (2011-2016)
Table United States Depression Drugs Sales Market Share by Application (2011-2016)
Figure United States Depression Drugs Sales Market Share by Application in 2015
Table United States Depression Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Depression Drugs Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Depression Drugs Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Depression Drugs Sales Market Share (2011-2016)
Table APOTEX Basic Information List
Table APOTEX Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table APOTEX Depression Drugs Sales Market Share (2011-2016)
Table PRINSTON INC Basic Information List
Table PRINSTON INC Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table PRINSTON INC Depression Drugs Sales Market Share (2011-2016)
Table TEVA Basic Information List
Table TEVA Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table TEVA Depression Drugs Sales Market Share (2011-2016)
Table ROXANE Basic Information List
Table ROXANE Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ROXANE Depression Drugs Sales Market Share (2011-2016)
Table ZYDUS PHARMS Basic Information List
Table ZYDUS PHARMS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ZYDUS PHARMS Depression Drugs Sales Market Share (2011-2016)
Table SUN PHARM Basic Information List
Table SUN PHARM Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table SUN PHARM Depression Drugs Sales Market Share (2011-2016)
Table JUBILANT GENERICS Basic Information List
Table JUBILANT GENERICS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table JUBILANT GENERICS Depression Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Depression Drugs Sales Market Share (2011-2016)
Table Beijing Wansheng Basic Information List
Table Huahai Basic Information List
Table Jianfeng Basic Information List
Table Cadista Basic Information List
Table Carbosynth Limited Basic Information List
Table LGM Pharma Basic Information List
Table Intellipharmaceutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Depression Drugs
Figure Manufacturing Process Analysis of Depression Drugs
Figure Depression Drugs Industrial Chain Analysis
Table Raw Materials Sources of Depression Drugs Major Manufacturers in 2015
Table Major Buyers of Depression Drugs
Table Distributors/Traders List
Figure United States Depression Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Depression Drugs Production Forecast by Type (2016-2021)
Table United States Depression Drugs Consumption Forecast by Application (2016-2021)
Table United States Depression Drugs Sales Forecast by States (2016-2021)
Table United States Depression Drugs Sales Share Forecast by States (2016-2021)